Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 55 of 56
The slide uses a split-screen diagram to contrast physiological affinity vs high affinity in the context of FcRn-mediated antibody recycling.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 list 1/1 source-note 1/1 title 1/1
Components 4
process bullet source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1